Metabolic changes may precede proteostatic dysfunction in a Drosophila model of amyloid beta peptide toxicity
Open Access
- 1 May 2016
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 41, 39-52
Abstract
No abstract availableKeywords
Funding Information
- Wellcome Trust (082604/2/07/Z)
- University of Cambridge
- University of Copenhagen
- MedImmune
This publication has 73 references indexed in Scilit:
- Testing the Therapeutic Potential of Doxycycline in a Drosophila melanogaster Model of Alzheimer DiseaseJournal of Biological Chemistry, 2011
- The metabolic footprint of aging in miceScientific Reports, 2011
- Interplay between NS3 protease and human La protein regulates translation-replication switch of Hepatitis C virusScientific Reports, 2011
- Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans agingProceedings of the National Academy of Sciences, 2009
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memoryNature Medicine, 2008
- An optimized transgenesis system for Drosophila using germ-line-specific φC31 integrasesProceedings of the National Academy of Sciences, 2007
- Alzheimer's diseaseThe Lancet, 2006
- Oxidative Stress, Accumulation of Biological 'Garbage', and AgingAntioxidants & Redox Signaling, 2006
- Mechanisms of aging: public or private?Nature Reviews Genetics, 2002
- A C. elegans mutant that lives twice as long as wild typeNature, 1993